OSTEOTECH (OSTE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OSTEOTECH (OSTE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jose Kranz who wrote (109)	10/1/1998 2:40:00 PM
From: majormember	Read Replies (1) of 141

Jose....this is part of reason why....once they come out with the .26 share earnings, with a better market come Nov, I wouldn't rule $30 out......Regards, Skane ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ " NEW YORK, Oct 1 (Reuters) - Osteotech Inc (NASDAQ:OSTE) said its shares tumbled Thursday after BancBoston Robertson Stephens downgraded the company on concerns its third quarter revenues would fall short of expectations. Robertson Stephens analyst Wade King lowered his rating on Osteotech to buy from strong buy, citing "seasonal summer softness and a scheduled plant shutdown" during the third quarter. King trimmed his third quarter revenue estimate to $14.4 million from $15.5 million. But he stuck to his forecast that Osteotech would deliver diluted per share earnings of $0.26 in the third quarter -- 44 percent higher than the 1997 quarter. Osteotech, an Eatontown, N.J., company which manufactures orthopedic and surgical products, was off 5-15/16 to 20-9/16 in afternoon trade.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next